Risk and Reward
Randy Davis needed a second chance — and Cal State East Bay gave it to him
It was June 2014, at 58-years-old, when Randy Davis (BS ’02, Biological Sciences; MS ’06 Biological Sciences) got the news: The multinational Swiss healthcare company Roche was going to purchase his electronic DNA sequencing chip to the tune of $125 million. And if the chip could meet certain targets in detecting and reading DNA over the next several years — not entirely proven at the time of Roche’s acquisition — Davis and his colleagues would receive an even bigger payout.
